mRNA |
GSK429286A |
GDSC1000 |
pan-cancer |
AAC |
0.091 |
0.004 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.004 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.005 |
mRNA |
methylstat |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.005 |
mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.005 |
mRNA |
T0901317 |
GDSC1000 |
pan-cancer |
AAC |
0.091 |
0.005 |
mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
QS11 |
GDSC1000 |
pan-cancer |
AAC |
0.097 |
0.005 |
mRNA |
GW843682X |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.006 |